Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia
Developed by Novo Nordisk (makers of Wegovy), CagriSema is a weekly injection that combines: Semaglutide (the active ingredient in Wegovy) Cagrilintide , which mimics the hormone amylin and increases feelings of fullness Together, they may help overcome the bodys natural slowdown in metabolism during weight loss
The medication simulates the GLP-1 hormone, encouraging insulin release, reducing glucagon levels, and slowing stomach emptying
This matters far beyond appearance
Doctors decide between prescribing tirzepatide or Ozempic based on several factors, including the patients specific health needs, weight loss goals, and medical history
M.IngeT